Publication

Refinement of Operating Characteristics for Model-Based TGI Metrics Decision Support to Ungate a Pivotal Trial in Oncology

Explore how model-based tumor growth inhibition metrics can support earlier Go/No-Go decisions and pivotal trial…

Certara2026 年 8 月 28 日

Webinar

The Road to First-in-Human: Model-Informed Decisions from Discovery to First Dose

Danielle Pillsbury2026 年 8 月 28 日

Video

See an AI assistant run a PK analysis

Watch an AI assistant run a full population PK analysis using the NLME MCP Server,…

Certara2026 年 8 月 28 日

Video

Watch TFL Studio kill the copy-paste era

Watch how TFL Studio helps PK and PD scientists build tables, figures, and listings up…

Certara2026 年 8 月 28 日

Video

See AI PK Reports in action

Watch how AI PK Reports uses generative AI to turn tables, figures, and listings into…

Certara2026 年 8 月 28 日

Video

From blank page to working model, fast

Watch how Model Designer brings cloud based pharmacometric modeling to your browser, with guided wizards,…

Certara2026 年 8 月 28 日

Blog

Why pharmacometrics automation is the foundation of modern PK/PD

Pharmacometrics automation is reshaping PK/PD workflows. Explore five principles driving AI, cloud infrastructure, and model…

Sebastian Kuechenmeister2026 年 8 月 28 日

Webinar

How to Choose Your First-in-Human Dose Approach

Certara2026 年 8 月 17 日

Blog

A model-informed approach to radioligand therapy dosing under Project Optimus

Explore how targeted radionuclide therapy dosing uses QSP, biologically effective dose (BED), and exposure-response modeling…

Hunter Stephens, PhD2026 年 8 月 13 日

Webinar

Exploratory data analysis of a drug-biomarker-efficacy PD model

Certara2026 年 8 月 12 日

Modeling and Simulation – PK/PD

Refinement of Operating Characteristics for Model-Based TGI Metrics Decision Support to Ungate a Pivotal Trial in Oncology

The Road to First-in-Human: Model-Informed Decisions from Discovery to First Dose

See an AI assistant run a PK analysis

Watch TFL Studio kill the copy-paste era

See AI PK Reports in action

From blank page to working model, fast

Why pharmacometrics automation is the foundation of modern PK/PD

How to Choose Your First-in-Human Dose Approach

A model-informed approach to radioligand therapy dosing under Project Optimus

Exploratory data analysis of a drug-biomarker-efficacy PD model

订阅时事通讯

快捷链接

解决方案

联系我们